Cite Filings / GYRE / 0001140361-25-014780
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEFA14A

Proxy Materials

GYRE THERAPEUTICS, INC. · Filed 2025-04-21 · Acc 0001140361-25-014780

Documents 1

  • DEFA14A Proxy Materials , ny20044429x2_defa14a.htm

Around this filing

  • 2026-04-27 DEFA14A Proxy Materials
  • 2025-04-25 4 Chief Operating Officer acquired 650,000 shares (option exercise)
  • 2025-04-22 ARS Annual Report to Security Holders
  • 2025-04-21 DEFA14A Proxy Materials
  • 2025-04-21 DEF 14A Proxy Statement
  • 2025-04-18 4 Director acquired 15,000 shares (option exercise)
  • 2024-04-29 DEFA14A Proxy Materials

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading ny20044429x2_defa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…